Effects of advanced oxidation process on greywater treatment: an optimization study
International Advanced Researches and Engineering Journal · 2022
DOI: 10.35860/iarej.1091551 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Advanced Researches and Engineering Journal, 2022. Verfasst von Özlem DEMİR und 1 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Greywater is domestic wastewater from showers and sinks and has a significant potential for the protection of water resources as it is less polluted in terms of nutrients, inorganic substances and hazardous organic substances. It is aimed to treat and reuse greywater in order to meet the rapidly increasing water demand. In this research, the treatment of greywater using the Fenton Process was studied. The efficiency of the Fenton Process was optimized using the Box-Behnken Statistical Design Software. As a result of this study, 97.88 % of Chemical Oxygen Demand removal was achieved at pH = 3, Fe 2+ dose of 3 mM, H2O2 dose of 2 mM, and 37 min. The effect of Potassium Permanganate on the treatability of synthetic greywater was also investigated in the study. Results showed that 84% of the Chemical Oxygen Demand removal efficiency could be achieved using 0.1 g/L Potassium Permanganate at the end of 1 hour reaction time.
Zitieren
APA
DEMİR, Ö., & AKTAŞ, E. S. (2022). Effects of advanced oxidation process on greywater treatment: an optimization study. International Advanced Researches and Engineering Journal. https://doi.org/10.35860/iarej.1091551
Vancouver
DEMİR Ö, AKTAŞ ES. Effects of advanced oxidation process on greywater treatment: an optimization study. International Advanced Researches and Engineering Journal. 2022. doi:10.35860/iarej.1091551
BibTeX
@article{DEMR2022,
author = {DEMİR, Özlem and AKTAŞ, Ezgi Sühel},
title = {Effects of advanced oxidation process on greywater treatment: an optimization study},
journal = {International Advanced Researches and Engineering Journal},
year = {2022},
doi = {10.35860/iarej.1091551}
}
EUVIMED